Cardiawave
Manufacturing · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
bat b 3-5 Rue Jules Guesde, Levallois-Pe...Phone Number
(763) 504-1052Website
www.cardiawave.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Cardiawave
Cardiawave has developed a non-invasive medical device VALVOSOFT® for the treatment of valvular heart diseases, and in particular, Aortic Stenosis, the most prevalent heart valve disease in adults and one of the most common causes of cardiovascular mortality worldwide. Based in Paris, Cardiawave is a member of the national research consortium RHU Stop-AS, and has ISO 13485:2014 certification since 2019. Cardiawave employs 28 people and has secured over 22M in funding since its creation in 2014.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cardiawave your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cardiawave had a recent Job posting/layoffs
Product Launch: Get notified when Cardiawave launches new products
Website visits: Recent activity has been detected on your website
Check if Cardiawave has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Cardiawave
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cardiawave has new funding data
Cardiawave, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Cardiawave recently announced quarterly report
Check out if Cardiawave is spiking on competitors!
Recommended Actions
Find VP level buyers at Cardiawave
Find 2 more new buyers
Company Profile Activity
Activity Insights
Cardiawave is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cardiawave is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cardiawave.
Cardiawave Tech Stack
A closer look at the technologies used by Cardiawave
See more technologies
Cardiawave News & Media
Cardiawave appoints Olivier Pierron as its Chief Executive Officer
LEVALLOIS-PERRET, France--(BUSINESS WIRE)--Cardiawave SA, a French Medtech company that has developed an innovative Non-Invasive Ultrasound Therapy (NIUT) device for the treatment of severe symptomatic calcific aortic stenosis, is delighted to announce the appointment of Olivier Pierron as its new Chief Executive Officer. With more than 25 years of experience in cardiovascular therapies and a passion for innovation, Olivier Pierron brings to Cardiawave invaluable expertise in the development anCardiawave is presenting the 30-day follow-up results from its “Valvosoft® Pivotal Study” on the treatment of severe symptomatic aortic valve stenosis
LEVALLOIS-PERRET, France--(BUSINESS WIRE)--Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused Ultrasound Therapy (NIUT) device for the treatment of severe symptomatic calcific aortic stenosis, will present the 30-day follow-up results for 60 patients enrolled in its European pivotal study to the 73rd annual conference of the American College of Cardiology in Atlanta, Georgia. This is a leading event in the cardiovascular medicine calendar, which bringsCardiawave Announces the Publication in The Lancet of First-In-Human Clinical Studies Results With 40 Aortic Stenosis Patients Treated With Its Innovative Non-invasive Ultrasound Therapy (NIUT)
LEVALLOIS-PERRET, France--(BUSINESS WIRE)-- #Frenchtech--Cardiawave announces the publication in The Lancet of FIH results in phase II clinical studies with its innovative Non-Invasive Ultrasound Therapy.Cardiawave Granted New Patents for its Aortic Stenosis Tech in the US
Cardiawave SA, a deeptech medical device manufacturer that developed Valvosoft, a non-invasive medical device to treat aortic stenosis, announced the issuance of three new patents in the United States.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cardiawave
Sign Up For FreeTo access detailed company insights
Cardiawave has developed a non-invasive medical device VALVOSOFT® for the treatment of valvular heart diseases, and in particular, Aortic Stenosis, the most prevalent heart valve disease in adults and one of the most common causes of cardiovascular mortality worldwide. Based in Paris, Cardiawave is a member of the national research consortium RHU S... Read More
